Svanberg, E <br/><br/>
Anabolic effects of rhIGF-I/IGFBP-3 in vivo are influenced by thyroid status.  [electronic resource] 

 -  European journal of clinical investigation  Apr 2001 
 - 329-36 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2972 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2362.2001.00793.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Biomarkers--blood<br/>Collagen--blood<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections, Intravenous<br/>Injections, Subcutaneous<br/>Insulin-Like Growth Factor Binding Protein 3--administration & dosage<br/>Insulin-Like Growth Factor I--administration & dosage<br/>Male<br/>Middle Aged<br/>Peptide Fragments--blood<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins--administration & dosage<br/>Thyroid Gland--drug effects